Sufentanil promotes autophagy and improves ischemia -reperfusion -induced acute kidney injury via up -regulating microRNA -145.
10.11817/j.issn.1672-7347.2022.210602
- Author:
Yan LU
1
;
Zongfang PIAO
2
;
Jianling LI
3
;
Ling LI
3
;
Ruhong LI
4
Author Information
1. Department of Anesthesiology, Affiliated Hospital of Chengde Medical College, Chengde Hebei 067000. jsxb201908@163.com.
2. Department of Laboratory, Affiliated Hospital of Chengde Medical College, Chengde Hebei 067000, China.
3. Department of Anesthesiology, Affiliated Hospital of Chengde Medical College, Chengde Hebei 067000.
4. Department of Anesthesiology, Affiliated Hospital of Chengde Medical College, Chengde Hebei 067000. guoooswy@163.com.
- Publication Type:Journal Article
- Keywords:
acute kidney injury;
autophagy;
ischemia reperfusion;
microRNA-145;
sufentanil
- MeSH:
Animals;
Rats;
Acute Kidney Injury/pathology*;
Antagomirs;
Autophagy;
Beclin-1/metabolism*;
Creatinine;
Interleukin-6/metabolism*;
Ischemia;
Kidney/pathology*;
Lipocalin-2;
MicroRNAs/metabolism*;
Reactive Oxygen Species;
Reperfusion;
Reperfusion Injury/metabolism*;
Sufentanil/therapeutic use*;
Tumor Necrosis Factor-alpha;
Up-Regulation
- From:
Journal of Central South University(Medical Sciences)
2022;47(10):1315-1323
- CountryChina
- Language:English
-
Abstract:
OBJECTIVES:Sufentanil has a good protective effect on myocardial and liver injury caused by ischemia reperfusion (IR), but its protective effect on kidney is still unclear. This study aims to investigate whether sufentanil can prevent IR-induced acute kidney injury (AKI) and to determine whether its efficacy is related to miR-145-mediated autophagy.
METHODS:A total of 40 rats were randomly divided into 5 groups (n=8 in each group): A sham group, an IR group, a sufentanil group, a sufentanil+miR-145 inhibitor control group (an anti-NC group) and a sufentanil+miR-145 inhibitor group (an anti-miR-145 group). Except for the sham group, the other groups established a rat AKI model induced by IR. The sufentanil group, the sufentanil+anti-NC group, and the sufentanil+anti-miR-145 were injected with sufentanil (1 μg/kg) through femoral vein 30 min before ischemia. The sufentanil+anti-NC group and the sufentanil+anti-miR-145 group were injected with miR-145 inhibitor control or anti-miR-145 (80 mg/kg) through the tail vein before sufentanil pretreatment. The structure and function of kidneys harvested from the rats were evaluated, and the protein levels of autophagy-related proteins, oxidative stress levels, and apoptosis levels were measured.
RESULTS:Compared with the IR group, the renal structure and function were improved in the sufentanil group. The levels of blood urea nitrogen (BUN), creatinine (Cr), urinary kidney injury molecule 1 (KIM-1), neutrophil gelatinase related lipid transporter (NGAL), tumor necrosis factor-α (TNF-α), interleukin (IL)-1β, IL-6 and ROS were significantly decreased (all P<0.05). In addition, compared with the IR group, the levels of Beclin-1 and LC3 in renal tissues in the sufentanil group were significantly increased (both P<0.05), and the apoptosis in renal tissues was significantly reduced (P<0.05). Compared with the sufentanil+anti-NC group, the levels of BUN, Cr, KIM-1, NGAL, TNF-α, IL-1β, IL-6 and ROS in the sufentanil+anti-miR-145 group were significantly increased (all P<0.05), the levels of Beclin-1 and LC3 in renal tissues were significantly decreased (both P<0.05), and the apoptosis in renal tissues was significantly increased (P<0.05).
CONCLUSIONS:Sufentanil can prevent the AKI induced by IR, which is related to the up-regulation of miR-145-mediated autophagy.
